N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

US6521592B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Pharma Company · US

Inventors

• Soo S. Ko · Hockessin, US
• George V. DeLucca · Wilmington, US
• John V. Duncia · Newtown, US
• Joseph B. Santella · Springfield, US
• Daniel S. Gardner · Furlong, US

Key dates

• Filing date: Oct 23, 2001
• Grant date: Feb 18, 2003
• Expiry date: Oct 23, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.